[HTML][HTML] The challenge of targeting cancer stem cells to halt metastasis

A Agliano, A Calvo, C Box - Seminars in Cancer Biology, 2017 - Elsevier
Despite a continuing debate about the existence of cancer stem cells (CSCs), recent
discoveries have provided further support for their existence and their roles in drug …

Osteosarcoma treatment: state of the art

HT Ta, CR Dass, PFM Choong, DE Dunstan - Cancer and Metastasis …, 2009 - Springer
Osteosarcoma (OS) is a class of cancer originating from bone, mainly afflicting children or
young adults. It is the second highest cause of cancer-related death in these age groups …

Applications of machine learning in cancer prediction and prognosis

JA Cruz, DS Wishart - Cancer informatics, 2006 - journals.sagepub.com
Machine learning is a branch of artificial intelligence that employs a variety of statistical,
probabilistic and optimization techniques that allows computers to “learn” from past …

[HTML][HTML] Translational activation of HIF1α by YB-1 promotes sarcoma metastasis

AM El-Naggar, CJ Veinotte, H Cheng, TGP Grunewald… - Cancer cell, 2015 - cell.com
Metastatic dissemination is the leading cause of death in cancer patients, which is
particularly evident for high-risk sarcomas such as Ewing sarcoma, osteosarcoma, and …

Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents

EP Buddingh, ML Kuijjer, RAJ Duim, H Bürger… - Clinical Cancer …, 2011 - AACR
Purpose: High-grade osteosarcoma is a malignant primary bone tumor with a peak
incidence in adolescence. Overall survival (OS) of patients with resectable metastatic …

TWIST1 promotes invasion through mesenchymal change in human glioblastoma

SA Mikheeva, AM Mikheev, A Petit, R Beyer… - Molecular cancer, 2010 - Springer
Background Tumor cell invasion into adjacent normal brain is a mesenchymal feature of
GBM and a major factor contributing to their dismal outcomes. Therefore, better …

Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression

M Paoloni, S Davis, S Lana, S Withrow, L Sangiorgi… - BMC genomics, 2009 - Springer
Background Pulmonary metastasis continues to be the most common cause of death in
osteosarcoma. Indeed, the 5-year survival for newly diagnosed osteosarcoma patients has …

Osteosarcoma genetics and epigenetics: emerging biology and candidate therapies

JJ Morrow, C Khanna - Critical Reviews™ in Oncogenesis, 2015 - dl.begellhouse.com
Osteosarcoma is the most common primary malignancy of bone, typically presenting in the
first or second decade of life. Unfortunately, clinical outcomes for osteosarcoma patients …

Machine learning for endometrial cancer prediction and prognostication

V Bhardwaj, A Sharma, SV Parambath, I Gul… - Frontiers in …, 2022 - frontiersin.org
Endometrial cancer (EC) is a prevalent uterine cancer that remains a major contributor to
cancer-associated morbidity and mortality. EC diagnosed at advanced stages shows a poor …

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

S Ferrari, E Palmerini - Current opinion in oncology, 2007 - journals.lww.com
At present, patients with nonmetastatic osteosarcoma of the extremity aged less than 40
years have an expected 5-year survival rate of 70% with a chemotherapy regimen based on …